Expired Canadian patentCanada
Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
CA 2277365 C · Owner: Gilbert, Adrian · Inventors: Sela, Michael; Teitelbaum, Dvora; Gilbert, Adrian
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the treatment of multiple sclerosis by ingestion or inhalation of copolymer-1 and pharmaceutical compositions useful for such treatment.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 12, 1998 and granted April 12, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 12, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 12, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 12, 1998
GrantedApril 12, 2011
Term endedJanuary 12, 2018
Patent numberCA 2277365 C
Classification (IPC)A61K38/00 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.